A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants
Abstract The current COVID-19 pandemic has heavily burdened the global public health system and may keep simmering for years. The frequent emergence of immune escape variants have spurred the search for prophylactic vaccines and therapeutic antibodies that confer broad protection against SARS-CoV-2...
Guardado en:
Autores principales: | Zhenlin Yang, Yulu Wang, Yujia Jin, Yuanfei Zhu, Yanling Wu, Cheng Li, Yu Kong, Wenping Song, Xiaolong Tian, Wuqiang Zhan, Ailing Huang, Shanshan Zhou, Shuai Xia, Xiaoxu Tian, Chao Peng, Cuicui Chen, Yibing Shi, Gaowei Hu, Shujuan Du, Yuyan Wang, Youhua Xie, Shibo Jiang, Lu Lu, Lei Sun, Yuanlin Song, Tianlei Ying |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/06f49be0a9fe4fccae87b81c545ff0ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Yanqiu Gong, et al.
Publicado: (2021) -
ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
por: Ivan T. Lee, et al.
Publicado: (2020) -
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
por: Jiwan Ge, et al.
Publicado: (2021) -
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
por: Changhai Lei, et al.
Publicado: (2020) -
High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients
por: Chao Liu, et al.
Publicado: (2021)